According to a U.S. Centers for Disease Control and Prevention report, witnesses who could have potentially intervened were present during 44% of opioid overdose deaths, but rarely administered naloxone. Recognizing an important unmet need for education, U.S. Surgeon General Jerome Adams issued an opioid overdose and naloxone advisory in April, calling on patients, their loved ones and the public to learn the signs of an overdose and to talk with a doctor or pharmacist about getting naloxone. Adapt’s pilot initiative heeds this call to action.
“An accidental opioid overdose can happen at any time to those taking opioids, especially at higher doses,” said Seamus Mulligan, chairman and chief executive officer of Adapt. “Our new educational media campaign encourages friends and family members of those taking prescription opioids to take steps to be prepared to respond to a loved ones’ opioid overdose emergency by obtaining Narcan Nasal Spray, an emergency treatment for a known or suspected overdose.”
In the United States, 50 states have access laws for naloxone in place, including Narcan (naloxone HCl) Nasal Spray, and allow it to be purchased directly from a pharmacist without an individualized prescription from their doctor. Narcan Nasal Spray is covered by insurance plans for 97 percent of people in the U.S. with health insurance, and 76% of dispensed prescriptions have a co-pay of $10 or less.
Adapt’s Direct-to-Consumer advertisement will air in Augusta, GA.; Birmingham, AL.; Charlotte, NC; Jacksonville, FL.; Oklahoma City, OK; Pittsburgh, PA; Salt Lake City, UT; and Tucson, AZ.